Delivery Order SPE2DB20D3103-SPE2DB25FQ3D0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,267.94 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) under a firm fixed price contract. This award, announced on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $1,943.94 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL units), with an ultimate completion date of August 27, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,177.75 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML vials (10 ML) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $1,113.80 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL) on June 5, 2025, with an ultimate completion date of June 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Humalog 100 Unit/mL vials (10 mL) with a ceiling value of $2,355.50. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and represents a pediatric/non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,317.86 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is for 4,565,152,638 units of the drug Humalog (insulin lispro) in 10 mL vials, with a performance period through July 16, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Humalog 100 Unit/mL vial 10mL insulin medication. The contract is valued at $4,766.40 with a firm fixed price structure and an ultimate completion date of September 22, 2025. This delivery order was competitively awarded without set-aside designation and represents a child...
- This delivery order, valued at $1,025.32, awards AmerisourceBergen Drug Corp the supply of Humalog 100 Unit/mL vials (10 mL) for the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humalog 100 unit/mL vial 10mL. The delivery order, valued at $3,038.02, is a firm fixed-price contract that supports the DLA Troop Support Medical program. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. The contract does not have any set-aside designation, indicating...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humalog 100 unit/mL vial 10mL. The $3,528.80 firm fixed-price delivery order contract has an ultimate completion date of October 15, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3D0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) with a ceiling value of $1,130.64. The order, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of September 16, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will serve as the place of performance for this pharmaceutical supply contract. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen regularly supplies a broad portfolio of medications, vaccines, and medical supplies to support military and veteran healthcare systems. The company's established relationship with DLA and demonstrated capability to fulfill federal procurement requirements through open competition position it as a key provider for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/15/25 |